MELBOURNE, Australia--(BUSINESS WIRE)--Propanc Biopharma, Inc. (OTC: PPCB) (“Propanc”), a biopharmaceutical company developing new cancer treatments for patients suffering from recurring and ...
Platelet-rich plasma (PRP) therapy is an innovative, though well-established, approach to healing common injuries. It was first used in the 1970s by doctors specializing in blood disorders to treat ...
Platelet-rich plasma injections into the anterior vaginal wall enhance sexual function in premenopausal women.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results